Medical Capital Investment Fraud Attorneys
Representing Clients Throughout Miami, Los Angeles, New York City and Nationwide
Investors who bought Medical Capital notes may be entitled to recover their Medical Capital investment losses from the brokerage firms that sold the investments. To date, Medical Capital investors are still owed more than $1 billion. The evidence also supports findings that Medical Capital was a Ponzi scheme and that brokerage firms should have known.
Arbitration Claims Against Brokerage Firms that Sold Medical Capital Notes
Dimond Kaplan & Rothstein believes that brokerage firms, such as Securities America, First Allied Securities, National Securities Corporation, QA3 Financial, Capital Financial Services, and WFP Securities, failed to perform adequate due diligence before recommending and selling hundreds of millions of dollars of Medical Capital investments and/or failed to disclose all risk and facts about Medical Capital to investors, including that Medical Capital appeared to be a Ponzi scheme. Similar to cases that DKR lawyers have filed on behalf of many investors, Massachusetts securities regulators have sued brokerage firm Securities America for failing to inform investors about the risks and warning signs about the Medical Capital fraud.
It appears unlikely that investors will recover much of their Medical Capital investment losses from the Medical Capital receivership. We believe that filing Financial Industry Regulatory Authority (FINRA) arbitration claims against brokerage firms that sold the Medical Capital notes is one of the best ways to recover Medical Capital fraud investment losses. Dimond Kaplan & Rothstein, P.A. currently represents dozens of investors throughout the United States who have lost tens of millions of dollars in Medical Capital notes. Our attorneys have filed numerous Medical Capital arbitration claims and Medical Capital lawsuits on behalf of Medical Capital investors in an effort to recover Medical Capital investment losses from brokerage firms.